Clinical Trial Update: DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia [Phase 1, Phase 2]

View source ↗

Summary

The study investigating daxibotulinumtoxinA injection for Adductor Spasmodic Dysphonia (a voice disorder) completed Phase 1/2 trials and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adductor Spasmodic Dysphonia
• Spasmodic Dysphonia

Drugs mentioned

• DaxibotulinumtoxinA Injection (daxibotulinumtoxinA)

Snippet

Sponsor: University of California, San Francisco | Conditions: Adductor Spasmodic Dysphonia, Voice Disorders | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-03-27